Form D — Electra Therapeutics, Inc.
0001231919-25-000372 · filed Oct 30, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $184,133,425
- Reported amount sold
- $134,188,389
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Electra Therapeutics, Inc.
- CIK
- 2088082
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 230 EAST GRAND AVENUE, SUITE S-100
SOUTH SAN FRANCISCO, CA 94080 - Phone
- (888) 743-2290
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Thomas Geninatti, Ph.D. · DirectorSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
-
Beth Seidenberg, M.D. · DirectorSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
-
Carl Gordon, Ph.D. · DirectorSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
-
Matthew Fust · DirectorSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
-
Nancy Stagliano, Ph.D. · DirectorSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
-
Quehuong (Kathy) Dong, Pharm.D. · Executive OfficerSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗